WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Dicerna), a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, today announced that it was named one of the Top Biotech Companies to Watch for Windhover’s 17th Annual Euro-Biotech Forum, being held June 28-30, 2010 in Paris. Windhover’s Top Biotech Companies to Watch winners will be honored on Tuesday, June 29 and Martin D. Williams, senior vice president and chief business officer, will present a company overview at 5:00 p.m. the same day.
